Eschenbach Andrew C. Von is a director of TriSalus Life Sciences Inc.
Person profile
Roles
Address
Montgomery, Texas
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
TriSalus Life Sciences, Inc.
14 Aug 23
3
TriSalus Life Sciences, Inc.
14 Aug 23
4
Celularity Inc
16 Jun 23
4
Bausch & Lomb Corp
5 May 23
4
Radius Health, Inc.
15 Aug 22
4
Celularity Inc
15 Jul 22
4
Bausch & Lomb Corp
12 May 22
3
Bausch & Lomb Corp
5 May 22
4
Radius Health, Inc.
25 Jan 22
4
Celularity Inc
2 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Aug 23 | TLSI TriSalus Life Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 11.34 | 35,000 | 396.90 k | 35,000 |
14 Jun 23 | CELU Celularity Inc - Ordinary Shares | Class A Common Stock | Grant | Acquire A | No | No | 0 | 199,921 | 0.00 | 336,066 |
14 Jun 23 | CELU Celularity Inc - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 0.7503 | 277,778 | 208.42 k | 277,778 |
4 May 23 | BLCO Bausch + Lomb | Common Shares, No Par Value | Grant | Acquire A | No | No | 0 | 12,857 | 0.00 | 25,357 |